+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Congestive Heart Failure"

From
From
From
Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Cardiology at its Core. Edition No. 1 - Product Thumbnail Image

Cardiology at its Core. Edition No. 1

  • Book
  • May 2023
  • 272 Pages
Loading Indicator

Congestive Heart Failure (CHF) is a condition in which the heart is unable to pump enough blood to meet the body's needs. It is a common form of heart disease and is the leading cause of hospitalization in the United States. CHF is a progressive condition, meaning that it can worsen over time. Symptoms of CHF include shortness of breath, fatigue, and swelling in the legs and feet. Treatment for CHF typically includes lifestyle changes, medications, and in some cases, surgery. The CHF market within the context of cardiology is a rapidly growing one. It is estimated that over 5 million people in the United States are living with CHF, and this number is expected to increase in the coming years. As such, there is a need for new and innovative treatments to help manage the condition. Some companies in the CHF market include Novartis, Amgen, and Merck. These companies are developing new treatments and therapies to help manage the condition. Additionally, there are a number of smaller companies that are developing new technologies to help diagnose and monitor CHF. Show Less Read more